Home » Life-saving drug for systemic sclerosis unavailable in Italy and the EU, doctors: “Back to the 80s”

Life-saving drug for systemic sclerosis unavailable in Italy and the EU, doctors: “Back to the 80s”

by admin
Life-saving drug for systemic sclerosis unavailable in Italy and the EU, doctors: “Back to the 80s”

Doctors raise concerns over the unavailability of life-saving drugs for scleroderma patients

Doctors in Italy are sounding the alarm over the unavailability of ACE inhibitors in injectable solution, a vital drug for those suffering from scleroderma renal crisis due to systemic sclerosis. This chronic autoimmune disease, also known as scleroderma, is progressive and can have serious complications, including renal crisis.

According to Professor Roberto Giacomelli of the Campus Bio-Medico University Polyclinic of Rome, these ACE inhibitors are essential in saving the lives of patients with systemic sclerosis. However, the drugs, such as Enalapril 20 mg and Captopril 50 mg, are no longer available on the market in Italy or Europe and can only be found in the United States.

The unavailability of these drugs is causing concern among doctors as they are crucial in treating systemic sclerosis and preventing serious complications. Without proper treatment, scleroderma renal crisis can lead to death.

Since 2017, systemic sclerosis has been recognized as a rare disease, affecting 10-15% of patients with acute renal failure. The aggressive treatment of hypertension with ACE inhibitors has significantly improved the prognosis for these patients over the years.

Professor Giacomelli emphasized the importance of these drugs in reducing the mortality rate of scleroderma renal crisis and called for urgent action to make them available again. He believes that even though production has ceased in Italy, the State should have a supply of these life-saving drugs.

The Italian Sclerosis League Systemic has also joined the call for action, highlighting the gravity of the situation for patients with systemic sclerosis. The availability of these drugs is crucial in providing proper care and preventing life-threatening complications for those suffering from this autoimmune disease.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy